Preparation of N-.About.(1-Ethyl-Pyrrolidinyl-2)-Methyl]-2-Methoxy-5-Sulphamoyl-Benzami De

This invention relates to the preparation of N - [(1-ethyl-pyrrolidinyl-2)-methyl] -2-methoxy-5-sulphamoyl-benzamide.

According to the invention, a process for preparing N - [(1-ethyl-pyrrolidinyl-2)-methyl] -2-methoxy-5-sulphamoyl-benzamide comprises reacting 1-ethyl-2-aminomethyl-pyrrolidine and 2-methoxy-5-sulphamoyl-benzoic acid in the presence of phosphorous trichloride.

As reaction medium, pyridine can be used.

The reaction takes place according to the following schematic sequence: ##SPC1##

In a one liter flask with a stirrer, a condensor, a thermometer and a dropping funnel, 27 g (0.11 Mol) of 1-ethyl-2-aminomethyl-pyrrolidine and 560 ml of pyridine are introduced. The solution obtained is stirred and 5.6 g (0.04 Mol) of phosphorous trichloride dissolved in 64 ml pyridine are added drop-by-drop whilst maintaining the temperature at about 20.degree.C.

After stirring at 20.degree.C for an half-hour 14.8 g (0.064 Mol) of 2-methoxy-5-sulphamoyl-benzoic acid are added. The mixture is reflux heated during four and a half hours and allowed to rest overnight. The pyridine is then removed by distillation under vacuum and the residue extracted with 200 ml of 10 % hydrochloric acid. There is obtained a precipitate which is heated to about 70.degree.-80.degree.C and dissolved. This solution is treated with 15 ml of concentrated ammonia water. The precipitate formed is filtered, washed with water, and dried in a drying chamber at 50.degree.C.

16.2 g (Yield 74.3 %) of N - [(1-ethyl-pyrrolidinyl-2)-methyl] -2-methoxy-5-sulphamoyl-benzamide with a melting point of 178.degree.C are obtained.

N - [(1-ethyl-pyrrolidinyl-2)-methyl] -2-methoxy-5-sulphamoyl-benzamide is useful in the pharmaceutical industry as an intermediary product, in particular for the manufacture of pharmaceutical products for the treatment of sickness in the fields of gastroenterology and neurology.